myAMDteam

Photobiomodulation (PBM) is definitely generating buzz in the AMD community! It's a light-based therapy that uses specific wavelengths of light to support retinal health, reduce inflammation, and help preserve vision.

The big news is that in November 2024, the FDA authorized a PBM device called the Valeda Light Delivery Show Full Answer

Photobiomodulation (PBM) is definitely generating buzz in the AMD community! It's a light-based therapy that uses specific wavelengths of light to support retinal health, reduce inflammation, and help preserve vision.

The big news is that in November 2024, the FDA authorized a PBM device called the Valeda Light Delivery System specifically for dry AMD — which is a significant milestone since there have been very few treatment options for dry AMD until now. Here's what clinical trials showed about Valeda:

- Vision improvement and preservation lasting up to 24 months
- Most effective for those in early or intermediate stages of dry AMD
- Fewer people progressed to severe late-stage AMD
- No significant side effects were reported

The treatment itself is pretty straightforward — you sit at the device while an eye care professional administers light sessions lasting about 4 minutes each. A full course is typically 9 sessions over 3 to 4 weeks.

There's also an interesting case report where a person with dry AMD used a PBM device at home for 8 months and saw dramatic improvement in drusen (deposits under the retina). That said, this is just one case and results like that aren't guaranteed or fully understood yet.

It's worth asking your eye doctor whether Valeda or any PBM therapy might be a good fit for your specific situation!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

5 Treatments for AMD: Injections, Laser Therapy, and New Approaches

Vision-Saving Device for Dry AMD Lands FDA Authorization